Skip to main content
. 2017 Jan 2;8(7):11887–11895. doi: 10.18632/oncotarget.14431

Table 3. The blood toxicity of XC-591 treatment.

Treatment RBC (×1012/L) HGB (g/L) WBC (×109/L) PLT (×109/L) ALT (U/L) AST(U/L)
Control 7.6±0.3 138.2±13.6 7.3±0.5 543.7±18.9 32.6±2.3 98.6±6.8
XC-591(50mg/kg) 7.7±0.7 136.1±17.3 7.6±0.8 523.7±16.7 36.4±4.5 96.3±12.3
XC-591(100mg/kg) 7.5±0.5 141.2±15.4 7.5±0.9 537.9±21.5 35.3±3.5 96.4±6.4

Data are expressed as the mean±S.D.